Wegovy Cut BMI 13.5% in Children Ages 6 to 11 in NEJM Trial, but 70% Had Vomiting
A phase 3 trial found weekly semaglutide lowered BMI in children ages 6 to 11 with obesity, but vomiting was common and BMI rose after treatment stopped.
Medical Daily ·